Home » Medivir Hep C Drug Cures 80 Percent of Patients Post-Treatment
Medivir Hep C Drug Cures 80 Percent of Patients Post-Treatment
Medivir’s experimental hepatitis C treatment TMC435 cured as many as 80 percent of patients 24 weeks after treatment ended, suggesting that the therapy prevents the virus from surging back.
Bloomberg
Bloomberg
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May